|Your Patient is Diagnosed with Metastatic Pancreatic Cancer: Do You Know the Best Treatment Options? |
Tanios Bekaii-Saab, MD, FACP
|Release Date: August 16, 2018|
Expiration Date: August 16, 2019
Pancreatic cancer ranks as the third leading cause of cancer-related mortality in the United States, and experts are predicting that it will rise to second place in the next decade. The management of patients with metastatic pancreatic cancer continues to be challenging for clinicians, and few treatment options are available. However, new active areas of research are investigating first- and second-line therapies that may soon expand the treatment armamentarium. In this activity, Dr. Tanios Bekaii-Saab explores two of the latest front-line options being explored in advanced metastatic pancreatic cancer. He also discusses how front-line therapy choices could impact treatment options for second-line therapy.Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
|Begin, Earn CreditView Only, No Credit|